AqVida is Exhibitor on the CPHI
AqVida is a German pharmaceutical company specialised in the development, registration and distribution of finished...
AqVida Licenses in Technology for Generic Oxaliplatin
Despite fierce competition on generic Oxaliplatin, AqVida is convinced it can generate major sales of the product due to the low level of production costs and transfer prices.
The product will be available for out-licensing in August. AqVida has confirmed talks with several interested companies throughout Europe have been initiated.
This is the third such development by the company, which was founded in 2004 and is mainly known for its bio-similar Filgrastim, which is registered under the trade name Leucita in Russia and under registration in several other countries in Eastern Europe and Latin America.
More About This Company
AqVida Opens New Office in Bavaria, Southern Germany
As from October onwards, AqVida, located in Hamburg, will be also present in the south...
AqVida Active Pharmaceutical Ingredients List
AqVida is involved in the the development, registration and supply of generic oncology products and...